Multi-omic analysis reveals altered gut microbiome-associated serum metabolites in colorectal cancer, suggesting their potential utility for noninvasive early cancer and adenoma detection.
Gut microbiome reprogramming in patients with CRC is associated with alterations of the serum metabolome, and GMSMs have potential applications for CRC and adenoma detection.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: